Managing hematological malignancies in the COVID-19 era: 12 months on, what have we learned?

Join our expert faculty for this series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin’s lymphoma (NHL).

Pre-register for your chance to submit questions to our expert faculty in advance of each broadcast. During each live broadcast you will also be able to interact with our faculty to discuss these key topics of interest.

Learning objective:

After participating in this broadcast you should be able to:

• Describe how the management of patients with hematological malignancies has changed since the start of the COVID-19 pandemic   

Faculty:

• John Gribben (UK)
• Paolo Ghia (Italy)
• Christian Buske (Germany)